Skip to content
Explicyte Oncology CRO logo
  • Discovery

    FFPE target discovery

    Custom biospecimen sourcing

    Target identification & ranking

    Target expression profiling

    Data generation

    AI-ready Spatial Biology Datasets

    Explicyte 10x Genomics certified service provider

    Across Visium, Xenium, Chromium

    Explore 10x services →

    Emerging IO Targets: pipeline overview

    Browse database →
  • Preclinical

    Functional efficacy and MoA

    Tumor killing assays

    ADCC · T-cell · Antigen-specific

    Immune function & modulation

    Activation · Migration · MLR · Macrophage Polarization · Germinal Center Reaction

    Safety

    Cytokine release

    Additional capabilities

    Patient-Derived 3D tumor models

    Immune-native organoids · Tumor fragments

    Modality-specific assays

    ADCs · Multispecifics & engagers

    Xenium for cells

  • Trials

    Biomarker analysis

    Transcriptomic biomarkers

    Spatial transcriptomics · scRNAseq

    ISO-certified pathology services

    IHC/IF assay development · Assay validation · TLS scoring

    Peripheral biomarkers

    Proteomics · Flow cytometry · scRNAseq

    Explicyte is ISO 9001 and ISO 13485 certified for biomarker and immuno-oncology services

    Certified IHC/IF biomarker services

    Clinical-grade quality management

    Our tissue biomarker services →

    Explicyte 10x Genomics certified service provider

    10x Genomics-Certified Services

    Chromium X, Visium HD, Xenium

    Explore 10x-certified services →

  • Resources

    Publications

    Case studies

    Posters & abstracts

    IO Target Database

    Events & webinars

    News & press

  • About

    Company

    Commitments

    Careers

MultiOmics
Contact us

Target: CLAUDIN 4

Anti-Claudin Therapeutic Programs in Oncology – 2026 Database Available

anti claudin therapeutic programs database clinical trials

Explicyte Oncology CRO logo

The precision oncology CRO

229 cours de l’Argonne
33000 Bordeaux, France

Subscribe to our newsletter

By subscribing, you agree to receive Explicyte’s email updates, tailored to your interests based on the emails you open and the links you click. You can unsubscribe at any time. Privacy policy

Explicyte

  • About us
  • Commitments
  • News & Press
  • Careers
  • Contact

Discovery

  • FFPE tissues
  • Target identification
  • Target expression
  • Spatial biology for AI
  • 10x CSP services

Preclinical

  • Tumor killing
  • Immuno-modulation
  • Cytokine release
  • Patient-derived 3D models
  • ADC, Multispecifics

Trials

  • Transcriptomics
  • Peripheral markers
  • ISO-certified pathology
  • TLS detection

Multiomics

  • Atera
  • Xenium
  • Visium HD
  • scRNAseq
  • Digital pathology
  • Bioinformatics

Resources

  • Publications
  • Posters
  • Events & webinars
  • Case studies
  • IO targets database

© 2026 Explicyte. All rights reserved.

© 2026 Explicyte. All rights reserved.

    • Privacy policy
    • Terms of Use
    • Terms of service

 

Linkedin Youtube
Explicyte

Multiomics

Also at Explicyte Oncology CRO services Target discovery, preclinical assays & clinical biomarker services 10x Genomics Certified Service Provider

Spatial Biology

Overview
  • Atera
  • Xenium
  • Visium HD
  • GeoMx
  • Digital pathology

Liquid sample profiling

Overview
  • Chromium X
  • Olink Reveal proteomics
  • Multiplex flow cytometry

Bioinformatics

Overview
  • 10x Genomics data analysis
  • Bulk RNA-seq & GeoMx DSP data analysis
  • mIF & IHC image analysis
Contact us